2516-95-2Relevant articles and documents
Monitoring intracellular pH fluctuation with an excited-state intramolecular proton transfer-based ratiometric fluorescent sensor
Feng, Bin,Zhu, Yingli,Wu, Jiaxin,Huang, Xueyan,Song, Rong,Huang, Liu,Feng, Xueping,Zeng, Wenbin
supporting information, p. 3057 - 3060 (2021/04/12)
Intracellular pH is a key parameter related to various biological and pathological processes. In this study, a ratiometric pH fluorescent sensor ABTT was developed harnessing the amino-type excited-state intramolecular proton transfer (ESIPT) process. Relying on whether the ESIPT proceeds normally or not, ABTT exhibited the yellow fluorescence in acidic media, or cyan fluorescence in basic condition. According to the variation, ABTT behaved as a promising sensor which possessed fast and reversible response to pH change without interference from the biological substances, and exported a steady ratiometric signal (I478/I546). Moreover, due to the ESIPT effect, large Stokes shift and high quantum yield were also exhibited in ABTT. Furthermore, ABTT was applied for monitoring the pH changes in living cells and visualizing the pH fluctuations under oxidative stress successfully. These results elucidated great potential of ABTT in understanding pH-dependent physiological and pathological processes.
Preparation method of anticoagulation drug intermediate 5-methoxy-2-nitrobenzoic acid
-
Paragraph 0025, (2017/08/28)
The invention discloses a preparation method of an anticoagulation drug intermediate 5-methoxy-2-nitrobenzoic acid and belongs to the field of drug intermediate synthesis. Cheap 3-drug intermediate serves as a raw material, a nitratlon reaction is selectively carried out at proper temperature to synthesize 5-chloro-2-nitrobenzoic acid, methyl alcohol is used for carrying out a substitution reaction on chlorine under the effect of alkali, and the needed intermediate 5-methoxy-2-nitrobenzoic acid is obtained. The preparation method which has short steps, simple reactions and low cost and can achieve stable industrial production is provided for a key intermediate of an anticoagulation drug Betrixaban.
INHIBITORS OF STEAROYL-COA DESATURASE
-
, (2009/06/27)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.